Effect of month-long treatment with oral n-acetylcysteine on the oxidative stress and proteinuria in patients with diabetic nephropathy: A pilot study

Journal of Investigative Medicine

Volumn 58, Issue 1, 2010, Pages 28-31

  Saklayen, Mohammad G ^a   Yap, Jayson ^b   Vallyathan, Val ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Diabetes; Glutathione; Isoprostane; N acetylcysteine; Oxidative stress; Proteinuria

Indexed keywords

8 ISOPROSTANE; ACETYLCYSTEINE; ACONITATE HYDRATASE; ANTIOXIDANT; CREATININE; GLUTATHIONE PEROXIDASE; INSULIN; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DRUG EFFECT; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PILOT STUDY; PROTEIN URINE LEVEL; PROTEINURIA; TREATMENT DURATION; TREATMENT OUTCOME; URINALYSIS;

ACETYLCYSTEINE; AGED; ANTIOXIDANTS; CREATININE; DIABETIC NEPHROPATHIES; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PILOT PROJECTS; PROTEINURIA;

EID: 74249113582     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3181c5e9e9     Document Type: Article

References (17)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
2. Shah SV, Baliga R, Rajapurkar M, et al. Oxidants in chronic kidney disease. J Am Soc Nephrol. 2007;18:16-28.
3. Aslan M, Sabuncu T, Kocyigit A, et al. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients. Nutr Metab Cardiovasc Dis. 2007;17;734-740.
4. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008;57:1446-1454.
5. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180-184.
6. Duong MH, Mackenzie TA, Malenka DJ. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis. Catheter Cardiovasc Interv. 2005;64:471-479.
7. Atkuri KR, Mantovai JJ, Herzenberg LA, et al. N-acetylcysteineVa safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol. 2007;7:1-5.
8. Decramer M, Rutten-van Mölken M, Dekhuijzen PN, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet. 2005;365:1552-1560. (Pubitemid 40615404)
9. DiMari J, Megyesi J, Udvarhelyi N, et al. N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol. 1997;272:F292-F298.
10. Nakajima H, Takenaka M, Kaimori J-Y, et al. Activation of STAT signaling pathway in renal proximal tubular cells by albumin. J Am Soc Nephrol. 2004;15:276-285.
11. Koksel O, Ozdulger A, Ercil M, et al. Effect of N-acetylcysteine on oxidant-antioxidant balance in oleic acid induced lung injury. Exp Lung Res. 2004;30:431-436.
12. Xia Z, Guo Z, Nagareddy PR, et al. Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats. Eur J Pharmacol. 2006;544:118-125.
13. van Schooten FJ, Besaratinia A, De Flora S, et al. Effect of oraladministration of N-acetylcysteine. A multi-biomarker study in smokers. Cancer Epidemiol Biomarkers Prev. 2002;11:167-175.
14. Medved I, Brown MJ, Bjorksten AR, et al. N-Acetylcysteine enhances muscle cysteine and glutathione availability and attenuates fatigue during prolonged exercise in endurance trained individuals. J Appl Physiol. 2004;97:1477-1485.
15. Roberts LJ 2nd, Oates JA, Linton MF, et al. The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med. 2007;43:1388-1393.
16. Block G, Jensen CD, Morrow JD, et al. The effect of vitamin C and E on biomarkers of oxidative stress depends on baseline level. Free Radic Biol Med. 2008;45:377-384.
17. Renke M, Tylicki L, Rutkowski P, et al. The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease. A placebo-controlled, randomized, open, cross-over study. Kidney Blood Press Res. 2008;31:404-410.